Wikipedia -WSS

Wikipedia

author：fashion 2025-09-29 21:22:56 - browse：928

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Q&A: Jennifer Adair on making gene therapy available globally

explore

WSS

After traumatic brain injury, life support decisions can use more time

SCOTUS to consider access to abortion pill mifepristone

Melinda French Gates resigns from Gates Foundation

Cancer researcher Catriona Jamieson is sending tumors into space

What PEPFAR has meant on the ground in Ukraine

After traumatic brain injury, life support decisions can use more time

Wikipedia

Wikipedia

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Health care needs a new profession: neuroimaging counseling

BioMarin wins approval for gene therapy to treat hemophilia A

After sickle

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

MultiPlan and major insurers sued for alleged medical price

Walensky prepares to leave CDC — and Congress — behind

In diabetes hearing, Sanders takes on a new foe: food makers

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

After sickle

leisure time

MultiPlan and major insurers sued for alleged medical price

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Exact Sciences stock tumbles despite strong cancer detection sales

UnitedHealth financials solid despite Change Healthcare cyberattack

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Leukemia patients are helped by Syndax's new type of therapy

focus

explore

hotspot

focus